| 1 |
34731371 | mTOR inhibitor PP242 increases antitumor activity of sulforaphane by blocking Akt/mTOR pathway in esophageal squamous cell carcinoma. | 2022 Jan |
2 |
| 2 |
31409554 | The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. | 2021 Jun |
4 |
| 3 |
34316328 | Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis. | 2021 Jul 20 |
4 |
| 4 |
32443471 | Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer. | 2020 May 18 |
5 |
| 5 |
32476238 | Sulforaphane Inhibits Autophagy and Induces Exosome-Mediated Paracrine Senescence via Regulating mTOR/TFE3. | 2020 Jul |
1 |
| 6 |
32512849 | Chronic Sulforaphane Administration Inhibits Resistance to the mTOR-Inhibitor Everolimus in Bladder Cancer Cells. | 2020 Jun 4 |
2 |
| 7 |
28212891 | Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation. | 2017 May |
2 |
| 8 |
27553905 | Sulforaphane protects against rotenone-induced neurotoxicity in vivo: Involvement of the mTOR, Nrf2, and autophagy pathways. | 2016 Aug 24 |
3 |
| 9 |
23389114 | Sulforaphane inhibits growth of phenotypically different breast cancer cells. | 2013 Dec |
2 |
| 10 |
23251470 | Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. | 2012 |
1 |